- £66.28bn
- £78.56bn
- £30.33bn
- 87
- 47
- 95
- 92
REG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC GlaxoSK Capital PLC GlaxoSK Kabush.K GSK Capital B.V. - Publication of EMTN Suppl.Prospcts
AnnouncementREG - GSK PLC - Jemperli plus Zejula Trial Meets Endpoint
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Japan accepts Arexvy filing for at risk adults
AnnouncementREG - GSK PLC - Jemperli plus chemotherapy EU authorisation
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - GSK publishes provisional 2024 dividend dates
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - Block Listing Application
AnnouncementREG - GSK PLC - Holding(s) in Company
AnnouncementREG - GSK PLC - GSK announces positive DREAMM-7 headline results
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - Block listing Interim Review
AnnouncementREG - GSK PLC - Director/PDMR Shareholding
AnnouncementREG - GSK PLC - GSK receives positive CHMP opinion for momelotinib
AnnouncementREG - Allianz Global Invs - Top 10 Holdings
AnnouncementREG - GSK PLC - Total Voting Rights
AnnouncementREG - GSK PLC - 3rd Quarter Results
Announcement